InsiderTrades

Form 4 for AORT ARTIVION, INC.

Accepted 2023-03-01 00:00:00 ET · period of report 2023-02-23 · accession 0000784199-23-000052 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2023-03-01 2023-02-27+ AORT Maney Rochelle L. VP, Quality S - Sale $13.03 -1,284 28.1K -4% -$16.7K
M 2023-03-01 2023-02-23+ AORT Maney Rochelle L. VP, Quality A - Grant $1.38 +5,806 29.3K +25% +$8,036

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-27 S D 878 $12.94 25,017 D — — (F2) These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
2 Common Common Stock 2023-02-27 A D 790 $12.94 28,467 D — — (F2) These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
3 Common Common Stock 2023-02-23 A A 2,356 $0.00 25,895 D — — (F1) Represents performance stock units granted on Feb 23, 2022. Hundred percent (100%) were issued on Feb 23, 2023.
4 Common Common Stock 2023-02-28 S D 406 $13.24 28,061 D — — (F4) These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
5 Common Common Stock 2023-02-23 A A 4,240 $0.00 29,257 D — — (F3) Represents performance stock units granted on Feb 23, 2022. Fifty percent (50%) were issued on Feb 23, 2023. The remaining shares earned in connection with the Feb 2022 grant will be eligible to vest and be issued as follows: 25% on 02/23/2024, and 25% on 02/23/2025, assuming continued employment on the relevant vesting date.